Correlation Between 90331HPL1 and NOVARTIS
Specify exactly 2 symbols:
By analyzing existing cross correlation between US BANK NATIONAL and NOVARTIS CAP P, you can compare the effects of market volatilities on 90331HPL1 and NOVARTIS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 90331HPL1 with a short position of NOVARTIS. Check out your portfolio center. Please also check ongoing floating volatility patterns of 90331HPL1 and NOVARTIS.
Diversification Opportunities for 90331HPL1 and NOVARTIS
Average diversification
The 3 months correlation between 90331HPL1 and NOVARTIS is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding US BANK NATIONAL and NOVARTIS CAP P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NOVARTIS CAP P and 90331HPL1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US BANK NATIONAL are associated (or correlated) with NOVARTIS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NOVARTIS CAP P has no effect on the direction of 90331HPL1 i.e., 90331HPL1 and NOVARTIS go up and down completely randomly.
Pair Corralation between 90331HPL1 and NOVARTIS
Assuming the 90 days trading horizon US BANK NATIONAL is expected to under-perform the NOVARTIS. In addition to that, 90331HPL1 is 1.38 times more volatile than NOVARTIS CAP P. It trades about -0.2 of its total potential returns per unit of risk. NOVARTIS CAP P is currently generating about -0.04 per unit of volatility. If you would invest 8,328 in NOVARTIS CAP P on September 1, 2024 and sell it today you would lose (49.00) from holding NOVARTIS CAP P or give up 0.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
US BANK NATIONAL vs. NOVARTIS CAP P
Performance |
| Timeline |
| US BANK NATIONAL |
| NOVARTIS CAP P |
90331HPL1 and NOVARTIS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 90331HPL1 and NOVARTIS
The main advantage of trading using opposite 90331HPL1 and NOVARTIS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 90331HPL1 position performs unexpectedly, NOVARTIS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NOVARTIS will offset losses from the drop in NOVARTIS's long position.| 90331HPL1 vs. Centessa Pharmaceuticals PLC | 90331HPL1 vs. Catalyst Pharmaceuticals | 90331HPL1 vs. Acumen Pharmaceuticals | 90331HPL1 vs. Inhibrx |
| NOVARTIS vs. Pekin Life Insurance | NOVARTIS vs. Ameriprise Financial | NOVARTIS vs. United Fire Group | NOVARTIS vs. The Hanover Insurance |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |